The document discusses Esotid, a proton pump inhibitor medication that is the highest prescribing, highest purchasing, and highest bioavailable in the Bangladesh pharmaceutical market. It provides sales figures for Esotid over four quarters showing increasing revenue. The document also outlines promotional support and gifts being provided to physicians in March 2018 to promote Esotid, including showcards, samples of different Esotid products, and a double sided grill pan allocated selectively to the highest Esotid prescriber in each territory.